Objective To analyze the effect of TEG based antithrombotic therapy on neurological recovery in patients with acute atherosclerotic cerebral infarction (ACI). Methods Totally 184 patients with ACI in our hospital were involved in this study. Patients received aspirin (group A), clopidogrel (group B) or clopidogrel plus aspirin (group C) 46 cases for each group. Choice of anti-platelet therapy in group D were determined by TEG (n?=?46). NIHSS score, ADL score, the positive rate of MES, the incidence of stroke recurrence rate and the rate of hemorrhagic events before and after treatment were recorded. Results Anti-platelet therapy induced a significant decrease of NIHSS score as well as MES positive rate and increase of ADL score in four groups when compared with those prior to any treatments (P?0.05). NIHSS score as well as MES positive rate were decreased while ADL score were increased obviously in C and D group when compared with those in group A and B (P?0.05). There was no significant difference between group C and D (P?>?0.05). Effective rate in C and D group were significantly higher while recurrence rate was lower than those in group A and B (P?0.0167). There was no significant difference between group C and D two groups (P?> 0.05). There was no statistically significant difference in gastrointestinal discomfort and mortality among the four groups (P?>?0.05). The incidence of bleeding events in group B and D were significantly lower than group C (P?< 0.0167). Conclusions Personized anti-platelet therapy based on TEG is more efficient with less bleeding events in the treatment of the patients with ACI.